First, transfusion of allogeneic blood products activatessystemic inflammatory responses and releases pro-inflammatory cytokines (e.g.,interleukin 6, tumor necrosis factor-α), leading to pulmonary capillaryleakage and alveolar edema, which in turn exacerbates respiratory insufficiency[18]. The gene discussed is TNF; the disease is Respiratory insufficiency.